Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Licensing

Dáil Éireann Debate, Wednesday - 6 March 2019

Wednesday, 6 March 2019

Ceisteanna (159)

Clare Daly

Ceist:

159. Deputy Clare Daly asked the Minister for Health if Pembrolizumab has received marketing authorisation here and in the EU, respectively, for the treatment of cervical cancer. [10972/19]

Amharc ar fhreagra

Freagraí scríofa

I wish to advise the Deputy that Pembrolizumab does not have a marketing authorisation for the treatment of cervical cancer in Ireland or the EU.

Barr
Roinn